Objective: To describe the epidemiological and etiological features of heart failure with preserved ejection fraction in our context. Materials and Methods: This is a retrospective study that was carried out over a 12-month period, from 1 January 2015 to 31 December 2015, in the hospitalization department of the Heart Institute of Abidjan. It was about patients hospitalized for heart failure who had received a dose of NT-proBNP and who had had an electrocardiogram, and a Doppler echocardiography. Heart failure with preserved ejection fraction (HFPEF) was defined from the symptoms and signs of heart failure, the level of NT-proBNP and from echocardiography data based on the left ventricular ejection fraction (LVEF) > 50%, the dilatation of the left atrium. The diastolic dysfunction of the left ventricle was assessed by the ratio E/E' > 13. We defined as heart failure with decreased ejection fraction (HFDEF) symptoms and signs of heart failure and left ventricular dysfunction LVEF < 40%. A computer file was completed. It included epidemiological and etiological data. Results: The study involved sixty-four patients with heart failure with preserved ejection fraction out of 257 patients with heart failure that is a prevalence of 25%. The mean age was 57.3 ± 16 years. There was a male predominance that is 52% of cases. Congestive heart failure was predominant in 67%. NT-proBNP levels were 365 pg/ml on average. The average length of stay was 5.5 ± 3.1. Intra-hospital deaths were 4.6%. The etiologies are dominated by high blood pressure in 85.9%, followed by obesity in 28.1%, then by ischemic heart disease in 4.6%. There were no diabetic patients in this group. Conclusion: Heart failure with preserved ejection fraction is characterized in our regions by its occurrence in young male subjects. Congestive heart failure prevailed. The dominant etiology was high blood pressure.
Introduction
The concept of heart failure with preserved ejection fraction is relatively new.
Historically, the diagnosis of heart failure was based primarily on clinical criteria, and patients described in the studies were likely to be a mixture of heart failure with altered ejection fraction and heart failure with preserved ejection fraction. The generalization of echocardiography in the 1980s and the need for standardization of diagnosis for inclusion in large therapeutic trials led to the exclusion from studies patients with preserved left ventricular ejection fraction.
Studies have systematically focused on this population over the past 15 years, with a number of publications indexed in PubMed, from 13 in 2001 to 336 in 2014.
The profile of heart failure with preserved ejection fraction is known woman, in atrial fibrillation [1] [2] [3] [4] . However, in Africa, little work has been done on this type of heart failure and we do not have local data for this clinical entity.
It is therefore appropriate to describe the epidemiological and etiological features of this condition in our context.
Materials and Methods
It is a comparative and descriptive retrospective study of records of patients hospitalized for heart failure in the medical department of the Heart Institute of Abidjan over a 12 month-period, from 1 January 2015 to 31 December 2015.
Heart failure with preserved ejection fraction (HFPEF) has been defined by the presence of symptoms and/or signs of heart failure (HF), elevation of NT proBNP, demonstration of left ventricular ejection fraction (LVEF) > 50% at the Simpson Biplane, dilation of the left atrium assessed at the Simpson biplane (4 cavities or 2 cavities) when the volume of the left atrium is >32 ml/m 2 , left ventricular hypertrophy (LVH) assessed by the left ventricular mass index (LVMI) and the Relative parietal thickness (RPT)of the left ventricle, values systematically given by the ultrasound system, threshold values 110 g/m 2 in man and 95 g/m 2 in women. Thus, left ventricular hypertrophy (LVH) is said to be concentric when LVMI is high and the relative parietal thickness (RPT) > 0.45. Left ventricular hypertrophy (LVH) is said eccentric when LVMI is high and relative parietal thickness (RPT) < 0.45. We refer to concentric remodeling when LVMI is normal and RPT > 0.45). Diastolic dysfunction was assessed by the ratio be- All patients with clinical, biological heart failure and with LVEF between 40 and 49% were not selected in our study.
The echocardiographic parameters were obtained using a VIVID 3 brand ultrasound system with a 2.5 MHZ adult probe.
LVEF was measured by Teicholz or Simpson biplane (4 cavities, 2 cavities).
The measurement of LVEF by Teicholz was used in the absence of segmental kinetic disorder.
Heart failure with preserved ejection fraction and heart failure with altered ejection fraction accounted for 64 (25%)... and 193 (75%), respectively [5] [6] [7] [8] [9] .
High blood pressure was accepted when systolic blood pressure (SBP) was ≥140 mmHg and/or diastolic blood pressure (DBP) ≥ 90 mmHg.
Dilated cardiomyopathy was accepted according to the following criteria: dilation of the left ventricle (LV), overall kinetic disorder, homogeneous.
Valvular heart disease was accepted when there was an organ involvement.
Ischemic cardiopathy was accepted in case of a history of myocardial infarction that had benefited from coronary angiography or not, segmental contractility disorder in echocardiography.
Obesity was defined from the body mass index with a BMI > 30 kg/m 2 .
Diabetes was defined from fasting blood glucose with a level > 1.26 g/l and hbA1C > 7.
All patients with clinical, biological heart failure with LVEF between 40% and 49% were not selected in our study.
The results are presented by standard averages and deviations or by percentages.
Differences between patient groups according to LVEF were tested with the chi square test for categorical variables. The significance threshold was 0.05.
Results
The study involved Sixty-four patients with heart failure with preserved ejection fraction out of257 patients with heart failure that is a prevalence of 25%. (Table 3) . 
Discussion
Heart failure is an increasingly common condition in our context. In our work, 25% of patients hospitalized for heart failure had heart failure with preserved ejection fraction (HFPEF). This prevalence is close to that found in the American studies, 24% to 55% [10] [11] and in African studies in particular that of We did not find diabetics in our study, whereas in the work of Nurcan [21] and Mouhamed Cherif [12] , the prevalence of diabetes was 42.3% and 45%, respectively. And in the study of Tribouilly, diabetes was a poor prognostic factor in patients with HFPEF. Its presence was associated with a 5-year survival of 32% and an increase in mortality of 60% compared with the group of non-diabetic patients [22] .
Limitations of the Study
The limitation of our study is mainly the unavailability of certain parameters of echocardiographies, namely the duration of the A wave at the pulsed Doppler of the pulmonary venous flow and the duration of the A wave at the pulsed Doppler of the mitral flow because they have not been set by our ultrasound system and because of the lack of experienced echocardiographers.
The current definition of heart failure with preserved ejection fraction (HFPEF) has limited the number of patients.
Conclusion
Heart failure with preserved ejection fraction is characterized in our regions by its frequent occurrence in the congestive mode, in young hypertensive men.
Complications of high blood pressure occur early and severe in the African black subject. We will insist on prevention which must be based on early screening and efficient management of this main cardiovascular risk factor in Africa.
